γδ T cells: origin and fate, subsets, diseases and immunotherapy

Y Hu, Q Hu, Y Li, L Lu, Z Xiang, Z Yin… - … and Targeted Therapy, 2023 - nature.com
The intricacy of diseases, shaped by intrinsic processes like immune system exhaustion and
hyperactivation, highlights the potential of immune renormalization as a promising strategy …

Cancer immunotherapy with γδ T cells: many paths ahead of us

D Kabelitz, R Serrano, L Kouakanou, C Peters… - Cellular & molecular …, 2020 - nature.com
Abstract γδ T cells play uniquely important roles in stress surveillance and immunity for
infections and carcinogenesis. Human γδ T cells recognize and kill transformed cells …

Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European …

P Ljungman, R de la Camara, C Robin… - The Lancet infectious …, 2019 - thelancet.com
Cytomegalovirus is one of the most important infections to occur after allogeneic
haematopoietic stem cell transplantation (HSCT), and an increasing number of reports …

Killer Ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation

D Pende, M Falco, M Vitale, C Cantoni… - Frontiers in …, 2019 - frontiersin.org
Natural killer (NK) cells contribute to the first line of defense against viruses and to the
control of tumor growth and metastasis spread. The discovery of HLA class I specific …

[HTML][HTML] NK cells and ILCs in tumor immunotherapy

S Sivori, D Pende, L Quatrini, G Pietra… - Molecular aspects of …, 2021 - Elsevier
Cells of the innate immunity play an important role in tumor immunotherapy. Thus, NK cells
can control tumor growth and metastatic spread. Thanks to their strong cytolytic activity …

[HTML][HTML] History of hematopoietic cell transplantation: challenges and progress

N Granot, R Storb - Haematologica, 2020 - ncbi.nlm.nih.gov
After more than 60 years of research in allogeneic hematopoietic cell transplantation (HCT),
this therapy has advanced from one that was declared dead in the 1960s to a standard …

Hematopoietic stem cell transplantation in its 60s: a platform for cellular therapies

C Chabannon, J Kuball, A Bondanza, F Dazzi… - Science translational …, 2018 - science.org
Over the last 60 years, more than a million patients received hematopoietic cell
transplantation. Having incorporated multiple changes in clinical practices, it remains a …

A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function

MT Lam, S Coppola, OHF Krumbach… - Journal of Experimental …, 2019 - rupress.org
Hemophagocytic lymphohistiocytosis (HLH) is characterized by immune dysregulation due
to inadequate restraint of overactivated immune cells and is associated with a variable …

The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell …

SO Ciurea, MM Al Malki, P Kongtim, EJ Fuchs… - Bone marrow …, 2020 - nature.com
The number of HLA-haploidentical hematopoietic cell transplants continues to increase
worldwide due to recent improvements in outcomes, allowing more patients with …

Graft-versus-host disease prophylaxis: Pathophysiology-based review on current approaches and future directions

N Martinez-Cibrian, R Zeiser, JA Perez-Simon - Blood reviews, 2021 - Elsevier
Graft-versus-host disease (GvHD) was first described in 1959, since then major efforts have
been made in order to understand its physiopathology and animal models have played a …